Automated Immunophenotype Classification for Hematological Disease Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing hematological diseases, such as leukemia, rely heavily on manual analysis of flow cytometry data, which is laborious, time-consuming, and prone to errors due to the subjective interpretation of vast amounts of data from flow cytometers.
Innovation Solution
An automated classification system that processes and transforms flow cytometry data into a more manageable format using machine learning algorithms, enabling the training and application of classification models to rapidly distinguish between different immunophenotypes and predict hematological disease types.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If manual analysis of flow cytometry data is used, then diagnostic accuracy can be achieved through expert interpretation, but the process becomes laborious and time-consuming
Solution Approach 1:
The patent replaces manual mechanical analysis with an automated computer-based system that uses machine learning algorithms to process flow cytometry data. The system automatically trains classification models on labeled datasets and applies them to new samples, eliminating the need for manual expert interpretation while maintaining diagnostic accuracy and significantly reducing analysis time.
Solution Approach 2:
The system enables self-service through automated model training and classification. The computer automatically performs data processing, model training, and disease type classification without requiring continuous manual intervention. The system serves itself by autonomously analyzing flow cytometry data and generating diagnostic results.
2Adaptability or versatility
If manual analysis is performed, then flexibility in interpretation is maintained, but human error and subjectivity increase
Solution Approach 1:
The patent transforms the analysis process by changing from subjective human interpretation parameters to objective computational parameters. The system uses standardized machine learning algorithms and classification models that consistently apply the same criteria to all samples, eliminating variability between different analysts while maintaining the ability to adapt to different disease types through configurable model training.
3Productivity
If automated classification systems are implemented, then processing speed increases, but system complexity increases
Solution Approach 1:
The patent implements a universal automated system that handles multiple flow cytometry analysis tasks through a single platform. The computer-based system performs data import, preprocessing, model training, and classification for various hematological diseases using the same infrastructure, reducing overall system complexity compared to multiple specialized manual analysis systems.
4Loss of information
If vast amounts of flow cytometry data are analyzed manually, then comprehensive diagnosis is possible, but the workload becomes unmanageable
Solution Approach 1:
The patent extracts and processes only the most relevant features from vast flow cytometry datasets using automated algorithms. The system identifies key parameters and patterns that are most indicative of different disease types, filtering out redundant information while maintaining comprehensive diagnostic capability. This extraction approach makes the analysis manageable by focusing on critical data points.
Data Source
AI summary
Introduced here is an approach to improving the automatic identification of hematological diseases using computer-implemented models that are trained to rapidly distinguish between different collections of immunophenotypes that represent different disease types or disease states. Understanding the different patterns of immunophenotype collections contained in a given sample may permit a proposed diagnosis for a given hematological disease to be produced for the corresponding patient. For example, the proposed diagnoses may be output by a classification model based on the distribution of immunophenotypes across the given sample.